InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+12.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by GOTTSCHALK ADRIAN, Chief Executive Officer. Director active across 1 company, notably Foghorn Therapeutics Inc.. Cumulatively, 8 filings have been published. History available since 20 August 2021. The latest transaction was filed on 25 April 2025 (Don). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
300,000 shares0Common StockSEC:0001562180-25-003257:0
197,906 shares0Common StockSEC:0001562180-25-003092:0
63,000 shares0Common StockSEC:0001562180-23-006432:0
300,000 shares0Common StockSEC:0001562180-23-004642:0
123,479 shares0Common StockSEC:0001562180-23-001675:0
40,000 shares@ US$0.5450.4% of flowCommon StockSEC:0001562180-22-006726:0
23,000 shares@ US$0.540.0035% mcap50.0% of flowCommon StockSEC:0001562180-21-005521:0
23,000 shares@ US$0.5424.8% of flowCommon StockSEC:0001562180-21-005521
8 of 8 declarations
About GOTTSCHALK ADRIAN
Adrian Gottschalk is the Chief Executive Officer of Foghorn Therapeutics Inc. He oversees the company's operations and is responsible for implementing the business strategy. Adrian plays a crucial role in leading the company and making strategic decisions. His leadership is essential for ensuring Foghorn's growth and success.
